Empowering Advocacy Through Regulatory Insight: EMA Training for Bleeding Disorders Community
The European Haemophilia Consortium shared a thrilled post on advancing advocacy on X:
”Great to participate in European Medicines Agency training for patients and healthcare professionals! EHC SC Member Marius Tanase joined sessions on scientific advice, regulatory pathways and document review. Valuable insights for Patient Advocacy work!”
Great representation from the bleeding disorders community at the European Medicines Agency (EMA)!
EHC Steering Committee Member Marius Tanase recently took part in a specialized training organized by the EMA for patients and healthcare professionals.
This hands-on experience provided valuable insights that will directly strengthen the efforts, ensuring that patient voices remain central to therapeutic innovation and decision-making processes!
Learn more on coming conferences and trainings in Hemostasis Today.
-
Apr 12, 2026, 22:12Maciej Banach: The ‘Metastatic’ Cardiovascular Threat We Can No Longer Ignore
-
Apr 12, 2026, 21:52Umar Jawed: The Most Dangerous Anti-D Result Is Not the Highest One – It’s the One You Underestimate Early
-
Apr 12, 2026, 21:37Demosthenes Panagiotakos: Hellenic Atherosclerosis Society Calls for Papers on Innovative Strategies in Atherosclerotic Plaque Management
-
Apr 12, 2026, 21:24Heghine Khachatryan: Diagnosing PNH in Resource-Limited Settings
-
Apr 12, 2026, 21:15Katariina Öörni: Role of Cholesterol Absorption Efficiency in Atherosclerosis
-
Apr 12, 2026, 17:34Caitlin Raymond: Granulocyte Transfusions for the Overworked Fellow
-
Apr 12, 2026, 17:33Augustina Isioma Ikusemoro: ABO Typing Is Not the Same in Infants and Adults
-
Apr 12, 2026, 17:32Bastu Odoka: Same Blood Group Does Not Guarantee Compatibility
-
Apr 12, 2026, 17:31Jack Hadfield: SARS-CoV-2–Associated Lasting Mitochondrial Injury in Cardiomyocytes